This site is intended for US residents only
This site is intended for US residents only.
  •  
  • COMPANY ▾
    • TEVA GLOBAL
    • VISION + VALUES
    • HISTORY
    • SPECIALTY AREAS
      • CNS
      • Oncology
      • Respiratory
      • Select Brands
      • Women's Health
    • GOVERNMENT AFFAIRS
    • CONTACT
  • MEDICINES ▾
    • SPECIALTY MEDICINES
    • GENERIC MEDICINES
    • MEDICAL AFFAIRS
      • Medical Information
      • Medical Education
    • QUALITY + SAFETY
    • TRADE PARTNERS
      • Return Goods Policy
      • Terms and Conditions
      • ADR Products
  • RESPONSIBILITY ▾
    • CORPORATE SOCIAL RESPONSIBILITY
      • Corporate Charitable Donations
      • Access to Medicine
      • Volunteerism
    • ADVOCACY
    • COMPLIANCE
    • RELATIONSHIPS WITH HCPs
  • CAREERS ▾
    • SEARCH JOBS
    • CAREERS FAQ
    • THE TEVA EXPERIENCE
    • TESTIMONIALS
  • NEWS ▾
    • MEDIA CONTACTS
    • FAST FACTS
    • MEDIA FAQ
Who We Are Medicines Integrity Values Careers
Teva for your whole life.

TEVA PHARMACEUTICALS IN THE US

Teva is working every day to make quality healthcare accessible. As a manufacturer of specialty and generic pharmaceuticals, Teva provides both new and innovative therapies and greater access to affordable medicines.


Learn more ▸

MEDICINES THAT FIT EVERYONE'S NEEDS

One in every eight prescriptions dispensed in the US is a Teva product.*

*IMS Health NPA MAT June 2014


Explore Generics

▸


Explore All Medicines

▸

NEWS

1.15.15Teva to Report Fourth Quarter 2014 Financial Results on February 5, 2015
1.8.15Teva to Present at the 33rd Annual J.P. Morgan Healthcare Conference
1.6.15Teva Launches Generic Diovan® in the United States
12.23.14FDA Approves Teva’s GRANIX® (tbo-filgrastim) Injection for Self-Administration
12.22.14Teva to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
12.19.14Teva Announces FDA Approval of QNASL® (Beclomethasone Dipropionate) Nasal Aerosol for Treatment of Children with Seasonal and Perennial Allergic Rhinitis
12.11.14Teva Provides 2015 Business Outlook
12.10.14Teva Announces Launch of First Generic Celebrex® Capsules in the United States
12.1.14Teva to Host 2015 Business Outlook Conference Call and Webcast on December 11, 2014
12.1.14Teva Announces Launch of Generic Exforge HCT® Tablets in the United States
More ▸
© Copyright 2014 Teva Pharmaceuticals USA
Supplier Portal   |   Privacy   |    Legal   |   Contact   |    Sitemap
COMPANY

 MEDICINES

 RESPONSIBILITY
TEVA GLOBAL

VISION + VALUES

HISTORY

SPECIALTY AREAS

GOVERNMENT
AFFAIRS

CONTACT 		SPECIALTY MEDICINES

GENERIC MEDICINES

MEDICAL AFFAIRS

QUALITY + SAFETY

TRADE PARTNERS 		CORPORATE SOCIAL
RESPONSIBILITY

ADVOCACY

COMPLIANCE

RELATIONSHIPS WITH HCPs
CAREERS

 NEWS
CAREERS FAQ

THE TEVA EXPERIENCE

TESTIMONIALS 		MEDIA CONTACTS

FAST FACTS

MEDIA FAQ